Levin Jeremy M's Form 4 filing
Ovid Therapeutics Inc. (OVID) · filed Dec 18, 2025
- Accession no.
- 0001256153-25-000004
- Filed
- Dec 18, 2025
- Trade date
- Dec 11-15, 2025
- Filing delay
- 7 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 4 derivative transactions. It was filed 7 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Levin Jeremy MCIK 0001256153 | Director, Officer (CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | Common Stock | CConversionAcquired | +71,000 | – | – | 3,687,715 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | Common Stock | PPurchaseAcquired | +71,000 | – | – | 71 | Direct | |
| Dec 11, 2025 | Common Stock | PPurchaseAcquired | +47,333 | – | – | 47,333 | Direct | |
| Dec 11, 2025 | Common Stock | PPurchaseAcquired | +35,500 | – | – | 35,500 | Direct | |
| Dec 15, 2025 | Common Stock | CConversionDisposed | −71,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.